More tools:Markets·Screener·Research·Chat

Opus Genetics, Inc. Common Stock (IRD) Financial Statements

Opus Genetics, Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SC04V7
XNAS · usd
6.43▲ 2.09 (48.16%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)—
EBITDA—
Diluted EPS (TTM)—
EBITDA Margin—
Net Debt—
Trading Information
Previous Close4.34
Day's Range4.31 – 4.62
52-Week Range1.28 – 5.81
Volume2.3M
Avg Volume1.2M
Share Statistics
Shares Outstanding
Employees28
ExchangeXNAS
Listed2020-11-06
Share count as of August 3, 2026
Loading Income Statement…
Key questions about Opus Genetics, Inc. Common Stock (IRD)
What is Opus Genetics, Inc. Common Stock's Market Cap?
Opus Genetics, Inc. Common Stock's Market Cap is $534.9M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
License and collaborations revenue
YoY growth-73.8%-50.6%-10.2%-20.4%
Operating expenses:
Research and development
General and administrative
Total operating expenses
% of revenue2282.8%765.9%396.3%369.9%
Loss from operations
% of revenue-2182.8%-665.9%-296.3%-269.9%
Fair value change in instruments measured at fair value———
Financing costs
Other income, net
Loss before income taxes
Benefit (provision) for income taxes
Net loss
% of revenue-1072.6%-3038.2%-427.5%-566.9%
Basic (in dollars per share)
Diluted (in dollars per share)